3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Diabetes Mellitus, Type 2
1
Cushing Syndrome
1
ACTH Syndrome, Ectopic
1
Interventions
relacorilant
3
somapacitan
1
saxagliptin
1
mazdutide
1
dapagliflozin
1
Urine Specimen Collection
1
Sulfonylurea Compounds
1
Sodium-Glucose Transporter 2 Inhibitors
1
Nutrition Assessment
1
Dipeptidyl-Peptidase IV Inhibitors
1
Blood Specimen Collection
1
Biopsy
1
ASP3662
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Type 2
×
ASP3662
×
1 year
×
Clear all
NCT07296484
2026-05-12
CAPTAIN-T2D
Sparrow Pharmaceuticals
Phase 2
Recruiting
1,500 enrolled